Lantheus Holdings, Inc.

LNTH Healthcare Drug Manufacturers Specialty & Generic

Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024. In the quarter to June 2026, revenue grew 2.68%, EPS was flat, free cash flow grew 13.6% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.

99.70 0.29 −0.29%
Market cap
$6.5B
P/E
23.7×
Fwd P/E
25.3×
Dividend yield
—
F-score
5/9
Altman Z
4.25
Beneish M
−2.23
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
26.35 18.02 19.35 20.93

+8 more quarters

P/S ratio
4.64 3.18 2.91 2.26
P/FCF ratio
18.40 12.85 12.69 8.14
P/Operating CF
78.40 39.24 49.81 32.75
P/B ratio
5.51 4.05 4.12 3.08
Price to Tangible BV
18.85 18.40 35.23 24.70
EV/Sales
4.63 3.22 3.05 2.38
EV/EBITDA
18.23 13.33 12.20 8.73
EV/Operating CF
17.46 12.22 12.05 7.94
EV/FCF
18.35 13.04 13.28 8.58
Quick Ratio
2.82 2.57 2.20 2.21
Current Ratio
3.06 2.83 2.70 2.67
Net Debt/EBITDA
(0.18) 0.68 2.08 2.87
Debt/Assets
23.65% 24.31% 25.56% 24.99%
Debt/Equity
0.44 0.47 0.52 0.51
Asset Turnover
0.69 0.70 0.73 0.71
Operating CF/Net income
1.23 1.06 1.67 3.79
Capex/Depreciation
(0.10) 0.07 (0.37) (0.49)
Interest Coverage
20.39 16.72 15.20 8.81
Research and Development Expense of Revenue
9.84% 10.44% 11.67% 12.51%
Selling, General and Administrative Expense of Revenue
26.65% 29.21% 28.57% 34.04%
Intangible Assets out of Total Assets
0.38 0.40 0.43 0.43
Share Based Compensation of Revenue
5.15% 4.25% 4.31% 6.38%
Graham Net Nets
(0.01) (0.04) (0.05) (0.07)
Graham Number
43.67 42.12 35.35 30.29
Earnings Yield
3.79% 5.55% 5.17% 4.78%
Free Cash Flow Yield
5.43% 7.78% 7.88% 12.29%
Revenue per Share
5.96 5.83 6.03 5.71
Operating CF per Share
1.42 1.93 1.34 1.57
Capex per Share
(0.04) 0.03 (0.13) (0.16)
Free Cash Flow per Share
1.38 1.96 1.21 1.41
Cash per Share
9.11 7.70 5.32 5.68
Shareholders Equity per Share
20.13 18.73 16.15 16.65
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
20.13 18.73 16.15 16.65
Free Cash Flow
89.87 126.90 81.39 94.67
Working Capital
691.38 609.12 566.55 578.25
Capital Expenditures
(2.33) 1.77 (8.79) (10.62)
Net Current Asset Value
(75.82) (192.01) (237.64) (232.10)
EV/EBIT
23.84 17.17 15.13 10.46
Capex to Sales
0.01 0.00 0.02 0.03
Price to Operating Income
23.91 16.93 14.45 9.92
Other line items
Average Receivables
345.32 352.95 351.73 356.29
Average Payables
44.50 45.37 38.73 55.61
Average Inventory
59.85 65.23 66.35 66.44
Average Assets
2,265.37 2,200.91 2,103.87 2,163.02
Average Common Equity
1,239.28 1,188.24 1,088.90 1,149.46

Fold the line items

Columns are period end dates